![](/images/graphics-bg.png)
Cd44 expression and soluble cd44 as a potential marker of tumor load in pediatric acute leukemia
المؤلفون المشاركون
Hamdi, Nayyirah
Abd Al-Ghani, Nabilah A.
Azzah M.
Abd al-Qadir, Ibrahim A.
Shaban, Khalid A.
al-Sharqawi, Nahla M.
Ghalib, Fayiq M.
Atiyyah, Iman A.
المصدر
Journal of the Egyptian National Cancer Institute
العدد
المجلد 15، العدد 2 (30 يونيو/حزيران 2003)، ص ص. 129-135، 7ص.
الناشر
جامعة القاهرة المعهد القومي للأورام
تاريخ النشر
2003-06-30
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الموضوعات
الملخص EN
Background : CD44 standard transcript (CD44s) is known to be widely expressed on ANLL and in a high percentage of ALL where it is reported to correlate with tumor burden.
Different isoforms have been reported to be expressed on ANLL and/or ALL with various impacts on prognosis.
In the present study the expression of CD44s and its variant isoforms CD44v4, v6 and v7 / 8 were analyzed in 76 newly diagnosed children with acute leukemia and correlated with immunophenotyping, TLC and tumor burden.
Patients and Methods : the cases comprised 62 ALL and 14 ANLL cases, ALL cases included 42 males and 20 females with an age range of 1 to 17 years, a mean of 3.6 years and a median of 4 years.
ANLL cases included 4 males and 10 females with an age range of 2 to 16 years, a mean of 9 years and a median of 9.5 years.
Results : CD44s was detected on all ANLL and 98.3 % (61 / 62) of ALL cases tested.
CD44v4 was encountered, probably for the first time, in 7 / 52 ALL and 1 / 14 ANLL ; no other variants were encountered.
Serum CD44 (sCD44) level was elevated in 25 / 35 ALL and in 11 / 14 ANLL with no correlation to CD44s expression.
Conclusion : CD44 variant isoform expression could be used as a marker for monitoring minimal residual disease (MRD) in positive cases.
Serum CD44s levels can also be used as a tumor marker for follow up of patients and monitoring of therapy in ALL and ANLL cases independent of CD44 expression.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
al-Sharqawi, Nahla M.& Hamdi, Nayyirah& Atiyyah, Iman A.& Ghalib, Fayiq M.& Abd Al-Ghani, Nabilah A.& Shaban, Khalid A.…[et al.]. 2003. Cd44 expression and soluble cd44 as a potential marker of tumor load in pediatric acute leukemia. Journal of the Egyptian National Cancer Institute،Vol. 15, no. 2, pp.129-135.
https://search.emarefa.net/detail/BIM-68180
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
al-Sharqawi, Nahla M.…[et al.]. Cd44 expression and soluble cd44 as a potential marker of tumor load in pediatric acute leukemia. Journal of the Egyptian National Cancer Institute Vol. 15, no. 2 (Jun. 2003), pp.129-135.
https://search.emarefa.net/detail/BIM-68180
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
al-Sharqawi, Nahla M.& Hamdi, Nayyirah& Atiyyah, Iman A.& Ghalib, Fayiq M.& Abd Al-Ghani, Nabilah A.& Shaban, Khalid A.…[et al.]. Cd44 expression and soluble cd44 as a potential marker of tumor load in pediatric acute leukemia. Journal of the Egyptian National Cancer Institute. 2003. Vol. 15, no. 2, pp.129-135.
https://search.emarefa.net/detail/BIM-68180
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p.134-1235
رقم السجل
BIM-68180
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)